Participated · Seed · May 2026

Alkemio develops a modular, organic separation system designed to refine rare earth elements on-site at mines, starting with dysprosium. The company says its approach eliminates toxic solvents, cuts emissions by more than 70% and can reduce capex by up to 80% versus conventional large-scale refining. Founded three years ago by biotechnologist Ailín Svagzdys, second-time founder Federico Bonnet, and rare-earth separation scientist Lorena Molina Calderon, Alkemio has signed pilots and letters of intent with mining companies across Latin America, the U.S. and Canada. The startup previously raised $400,000 from accelerators GRIDX and SkyDeck Berkeley and will use the new $2 million pre-seed to scale its lab prototype into a 100-kilogram commercial pilot in the United States. Alkemio is part of a broader cohort of companies rethinking rare earth sourcing and processing.

Participated · Seed · Apr 2026

Plus1 is a social app that encourages users to post real plans and meet in person rather than swiping through profiles. Founder and CEO Jeff Wulkan presented the product and metrics at a private investor luncheon, highlighting traction after seven months: over 10,000 downloads, roughly 2,500 monthly active users, a 4.9-star App Store rating, and 47% retention. The company projects $1.5M in revenue in Year 1 and aims to reach $11.2M ARR by Year 3. Investor feedback at the luncheon focused on distribution, revenue, and geographic expansion beyond Miami. The team left the meeting with follow-up interest from several investors and intends to use insights from those conversations to inform go-to-market and growth plans. The article did not report current revenue or prior funding history.

Participated · Seed · Mar 2026

HEARTio’s core product, ECGio, applies deep-learning analysis to standard 12-lead electrocardiograms to predict the presence, severity and location of coronary artery blockages without invasive testing. Early validation work includes a study in the Canadian Journal of Cardiology and a larger JACC Advances study involving more than 16,000 patients that supported the model’s ability to identify coronary artery disease from routine ECGs. The company emphasizes a headless API that uses pre-deployed ECG hardware and integrates software agents to surface subtle abnormalities for clinicians. Leadership includes co-founders Utkars Jain, Adam Butchy and Michael Leasure, with John Marous as Executive Chairman and two co-Chief Commercialisation Officers. HEARTio has public goals to complete a pivotal study, obtain FDA clearance, begin generating revenue, and expand its product suite to additional cardiac indications. The founding story is partly rooted in personal loss, and the team has received recognition including Forbes 30 Under 30.

Participated · Series A · Feb 2026

Founded in 2016, San Diego-based Natilus is engineering a family of blended-wing-body (BWB) aircraft that reduce fuel consumption by 30 %, cut carbon emissions and operating costs by 50 %, and boost payload capacity by 40 %. Its first product, the KONA regional freighter, carries a 3.8-ton payload and is designed for both commercial freight and defense logistics, with a first full-scale flight targeted within 24 months. The company is concurrently developing the 200-plus-seat HORIZON EVO passenger jet, aimed at the Boeing 737 MAX and Airbus A321neo market and slated for entry into service in the early 2030s. Natilus has secured more than 570 aircraft pre-orders worth an estimated $24 billion from customers such as SpiceJet, Nolinor Aviation, Flexport and Ameriflight. The firm is pursuing FAA Part 23, Amendment 64 certification for KONA and evaluating a 250,000 sq ft factory capable of producing 60 units per year. By using existing engine technology and airport infrastructure, Natilus seeks to de-risk adoption and accelerate commercialization. The team includes alumni from Boeing, Northrop Grumman, Skunk Works, SpaceX and other leading aerospace organizations.

Participated · Series A · Sep 2025

Atomionics is a Singapore-based deep-tech startup focused on quantum sensing, with its flagship product Gravio—a portable, basketball-sized quantum gravimetry device that acts like a virtual X-ray of the Earth. By combining ultra-sensitive quantum sensors with AI-driven interpretation, Gravio can map subsurface terrain up to ten times faster than conventional techniques, helping mining and energy companies locate copper, lithium and other critical minerals more accurately and sustainably. The firm plans to use its technology to generate high-quality gravity datasets that underpin AI-powered decision-making across resource exploration and potential defense applications. Backed by new strategic capital, Atomionics will establish offices in Australia and the United States, using the Northern Territory as a launchpad for wider Australian deployment while also pursuing opportunities in North American commercial and national security sectors. The company’s investor base includes major mining, venture and government-related groups, providing market access and domain expertise. Although the company has not disclosed revenue or user metrics, its recent funding round underscores strong commercial interest in leveraging quantum sensing for critical mineral supply chains and strategic resource management.